Top Markets
#1 QuantixAI QuantixAI +63.61%
#2 GEKKO GEKKO +43.09%
#3 Versatize Coin Versatize Coin +39.99%
#4 UnifAI Network UnifAI Network +29.42%
#5 MowCat MowCat +29.40%
#6 Storj Storj +29.08%
#7 Pons Pons +28.88%
#8 Prom Prom +28.67%
#9 Kinesis Silver Kinesis Silver +23.94%
#10 Fake World Assets Fake World Assets +22.62%
Coin of the day
QuantixAI QuantixAI
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Kedudukan dalam Saham #20820
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Harga Saham
$0.50101
Modal Pasaran
$121.27M
Perubahan (1 hari)
-3.65%
Perubahan (1 tahun)
43.15%
Negara
US
Perdagangan Vaxart, Inc. (VXRT)

Kategori

Healthcare
Nisbah P/B bagi Vaxart, Inc. (VXRT)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Vaxart, Inc., nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Vaxart, Inc. dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH